nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisapride—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.68	1	CbGbCtD
Cisapride—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0467	0.162	CbGeAlD
Cisapride—HTR3A—cranial nerve—amyotrophic lateral sclerosis	0.0302	0.104	CbGeAlD
Cisapride—Iloperidone—SIGMAR1—amyotrophic lateral sclerosis	0.0221	1	CrCbGaD
Cisapride—HTR3A—nerve—amyotrophic lateral sclerosis	0.0155	0.0535	CbGeAlD
Cisapride—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.0122	0.0421	CbGeAlD
Cisapride—HTR2A—pons—amyotrophic lateral sclerosis	0.012	0.0416	CbGeAlD
Cisapride—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.0103	0.0355	CbGeAlD
Cisapride—HTR4—brain—amyotrophic lateral sclerosis	0.00985	0.034	CbGeAlD
Cisapride—DRD2—nerve—amyotrophic lateral sclerosis	0.00946	0.0327	CbGeAlD
Cisapride—HTR2A—appendage—amyotrophic lateral sclerosis	0.0088	0.0304	CbGeAlD
Cisapride—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00801	0.0277	CbGeAlD
Cisapride—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00709	0.0245	CbGeAlD
Cisapride—HTR3A—brainstem—amyotrophic lateral sclerosis	0.00664	0.0229	CbGeAlD
Cisapride—HTR2A—nerve—amyotrophic lateral sclerosis	0.00624	0.0216	CbGeAlD
Cisapride—HTR2C—brainstem—amyotrophic lateral sclerosis	0.00534	0.0185	CbGeAlD
Cisapride—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00467	0.0162	CbGeAlD
Cisapride—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00426	0.0147	CbGeAlD
Cisapride—DRD2—brainstem—amyotrophic lateral sclerosis	0.00406	0.014	CbGeAlD
Cisapride—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00372	0.0129	CbGeAlD
Cisapride—HTR3A—nervous system—amyotrophic lateral sclerosis	0.00348	0.012	CbGeAlD
Cisapride—HTR3A—central nervous system—amyotrophic lateral sclerosis	0.00335	0.0116	CbGeAlD
Cisapride—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00332	0.0115	CbGeAlD
Cisapride—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.00322	0.0111	CbGeAlD
Cisapride—HTR2A—embryo—amyotrophic lateral sclerosis	0.00292	0.0101	CbGeAlD
Cisapride—HTR2C—nervous system—amyotrophic lateral sclerosis	0.0028	0.00967	CbGeAlD
Cisapride—KCNH2—medulla oblongata—amyotrophic lateral sclerosis	0.00279	0.00964	CbGeAlD
Cisapride—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.00269	0.00931	CbGeAlD
Cisapride—HTR2A—brainstem—amyotrophic lateral sclerosis	0.00268	0.00926	CbGeAlD
Cisapride—HTR3A—brain—amyotrophic lateral sclerosis	0.00266	0.00919	CbGeAlD
Cisapride—HTR2B—nervous system—amyotrophic lateral sclerosis	0.00263	0.00908	CbGeAlD
Cisapride—CYP2A6—brain—amyotrophic lateral sclerosis	0.00261	0.00903	CbGeAlD
Cisapride—HTR2B—central nervous system—amyotrophic lateral sclerosis	0.00253	0.00875	CbGeAlD
Cisapride—KCNH2—spinal cord—amyotrophic lateral sclerosis	0.00249	0.0086	CbGeAlD
Cisapride—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00244	0.00843	CbGeAlD
Cisapride—HTR2C—brain—amyotrophic lateral sclerosis	0.00214	0.00739	CbGeAlD
Cisapride—DRD2—nervous system—amyotrophic lateral sclerosis	0.00213	0.00735	CbGeAlD
Cisapride—KCNH2—nervous system—amyotrophic lateral sclerosis	0.0021	0.00725	CbGeAlD
Cisapride—DRD2—central nervous system—amyotrophic lateral sclerosis	0.00205	0.00708	CbGeAlD
Cisapride—KCNH2—central nervous system—amyotrophic lateral sclerosis	0.00202	0.00698	CbGeAlD
Cisapride—HTR2B—brain—amyotrophic lateral sclerosis	0.00201	0.00694	CbGeAlD
Cisapride—DRD2—cerebellum—amyotrophic lateral sclerosis	0.002	0.00692	CbGeAlD
Cisapride—KCNH2—cerebellum—amyotrophic lateral sclerosis	0.00197	0.00682	CbGeAlD
Cisapride—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.00187	0.00646	CbGeAlD
Cisapride—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.00172	0.00595	CbGeAlD
Cisapride—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.00167	0.00576	CbGeAlD
Cisapride—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.00166	0.00573	CbGeAlD
Cisapride—DRD2—brain—amyotrophic lateral sclerosis	0.00163	0.00562	CbGeAlD
Cisapride—KCNH2—brain—amyotrophic lateral sclerosis	0.0016	0.00554	CbGeAlD
Cisapride—CYP2C8—brain—amyotrophic lateral sclerosis	0.00147	0.00507	CbGeAlD
Cisapride—HTR2A—nervous system—amyotrophic lateral sclerosis	0.0014	0.00485	CbGeAlD
Cisapride—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.00135	0.00467	CbGeAlD
Cisapride—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.00132	0.00456	CbGeAlD
Cisapride—CYP2B6—brain—amyotrophic lateral sclerosis	0.00132	0.00455	CbGeAlD
Cisapride—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.0013	0.00449	CbGeAlD
Cisapride—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.00128	0.00442	CbGeAlD
Cisapride—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00125	0.00432	CbGeAlD
Cisapride—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.00123	0.00425	CbGeAlD
Cisapride—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.0012	0.00416	CbGeAlD
Cisapride—HTR2A—brain—amyotrophic lateral sclerosis	0.00107	0.00371	CbGeAlD
Cisapride—CYP2D6—brain—amyotrophic lateral sclerosis	0.000977	0.00338	CbGeAlD
Cisapride—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.27e-05	0.0015	CbGpPWpGaD
Cisapride—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	1.26e-05	0.00149	CbGpPWpGaD
Cisapride—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.26e-05	0.00149	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—DAO—amyotrophic lateral sclerosis	1.26e-05	0.00149	CbGpPWpGaD
Cisapride—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.25e-05	0.00148	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	1.25e-05	0.00148	CbGpPWpGaD
Cisapride—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.24e-05	0.00147	CbGpPWpGaD
Cisapride—HTR2C—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	1.24e-05	0.00147	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	1.23e-05	0.00145	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.19e-05	0.00141	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	1.19e-05	0.00141	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	1.19e-05	0.0014	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	1.19e-05	0.0014	CbGpPWpGaD
Cisapride—HTR2B—GPCR ligand binding—C3—amyotrophic lateral sclerosis	1.17e-05	0.00139	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.17e-05	0.00138	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	1.12e-05	0.00133	CbGpPWpGaD
Cisapride—HTR2A—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	1.12e-05	0.00132	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	1.11e-05	0.00132	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.11e-05	0.00131	CbGpPWpGaD
Cisapride—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	1.1e-05	0.0013	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	1.1e-05	0.0013	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.09e-05	0.00129	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	1.09e-05	0.00128	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	1.08e-05	0.00128	CbGpPWpGaD
Cisapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	1.08e-05	0.00128	CbGpPWpGaD
Cisapride—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.08e-05	0.00127	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	1.08e-05	0.00127	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	1.06e-05	0.00126	CbGpPWpGaD
Cisapride—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.06e-05	0.00126	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	1.06e-05	0.00125	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	1.06e-05	0.00125	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	1.04e-05	0.00123	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.03e-05	0.00121	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	1.02e-05	0.0012	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	1.01e-05	0.0012	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.01e-05	0.0012	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.01e-05	0.00119	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	9.91e-06	0.00117	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.88e-06	0.00117	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	9.82e-06	0.00116	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	9.75e-06	0.00115	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	9.75e-06	0.00115	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	9.69e-06	0.00115	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	9.66e-06	0.00114	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	9.66e-06	0.00114	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	9.66e-06	0.00114	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	9.59e-06	0.00113	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	9.58e-06	0.00113	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	9.52e-06	0.00113	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	9.49e-06	0.00112	CbGpPWpGaD
Cisapride—HTR2A—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	9.47e-06	0.00112	CbGpPWpGaD
Cisapride—HTR2C—GPCR ligand binding—C3—amyotrophic lateral sclerosis	9.47e-06	0.00112	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	9.28e-06	0.0011	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.06e-06	0.00107	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.01e-06	0.00107	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.01e-06	0.00107	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	8.92e-06	0.00105	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	8.84e-06	0.00105	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	8.79e-06	0.00104	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	8.67e-06	0.00103	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	8.58e-06	0.00102	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	8.47e-06	0.001	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.44e-06	0.000998	CbGpPWpGaD
Cisapride—DRD2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	8.35e-06	0.000988	CbGpPWpGaD
Cisapride—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	8.32e-06	0.000984	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.29e-06	0.00098	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	8.26e-06	0.000977	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	8.26e-06	0.000977	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	8.24e-06	0.000975	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	8.22e-06	0.000972	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.22e-06	0.000972	CbGpPWpGaD
Cisapride—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	8.2e-06	0.00097	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	8.16e-06	0.000965	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	8.15e-06	0.000964	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	7.87e-06	0.000931	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	7.79e-06	0.000922	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—VCP—amyotrophic lateral sclerosis	7.73e-06	0.000914	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	7.73e-06	0.000914	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	7.7e-06	0.000911	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	7.68e-06	0.000909	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	7.66e-06	0.000906	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	7.66e-06	0.000905	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	7.55e-06	0.000893	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	7.53e-06	0.000891	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	7.51e-06	0.000888	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	7.49e-06	0.000886	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	7.22e-06	0.000854	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	7.2e-06	0.000851	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	7.09e-06	0.000839	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	7.08e-06	0.000838	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	7.05e-06	0.000833	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.02e-06	0.00083	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	6.99e-06	0.000826	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.97e-06	0.000825	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	6.93e-06	0.00082	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	6.82e-06	0.000807	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.81e-06	0.000806	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	6.71e-06	0.000794	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	6.65e-06	0.000786	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.63e-06	0.000784	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	6.61e-06	0.000782	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	6.6e-06	0.000781	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	6.57e-06	0.000777	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	6.51e-06	0.000769	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	6.5e-06	0.000769	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	6.37e-06	0.000754	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	6.37e-06	0.000754	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	6.02e-06	0.000712	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	6e-06	0.00071	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	5.97e-06	0.000706	CbGpPWpGaD
Cisapride—DRD2—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	5.94e-06	0.000702	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	5.87e-06	0.000694	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	5.83e-06	0.000689	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	5.82e-06	0.000689	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	5.81e-06	0.000687	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	5.8e-06	0.000686	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	5.77e-06	0.000683	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	5.71e-06	0.000675	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	5.69e-06	0.000673	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.6e-06	0.000662	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.5e-06	0.00065	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.47e-06	0.000647	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.42e-06	0.000641	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.37e-06	0.000635	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	5.36e-06	0.000634	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	5.35e-06	0.000633	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	5.34e-06	0.000632	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	5.29e-06	0.000626	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.25e-06	0.000621	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	5.09e-06	0.000603	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.07e-06	0.0006	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5e-06	0.000591	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	4.93e-06	0.000583	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	4.93e-06	0.000583	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	4.89e-06	0.000578	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.88e-06	0.000577	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.86e-06	0.000574	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.85e-06	0.000574	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.77e-06	0.000564	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.72e-06	0.000558	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.65e-06	0.000549	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	4.61e-06	0.000545	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.55e-06	0.000539	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	4.52e-06	0.000535	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.52e-06	0.000534	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.5e-06	0.000532	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.45e-06	0.000526	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	4.4e-06	0.00052	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.29e-06	0.000507	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.28e-06	0.000506	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.24e-06	0.000501	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.23e-06	0.0005	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.22e-06	0.000499	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	4.18e-06	0.000494	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	4.05e-06	0.000479	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.03e-06	0.000477	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.02e-06	0.000476	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.02e-06	0.000475	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	4.01e-06	0.000475	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.99e-06	0.000471	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.92e-06	0.000464	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.89e-06	0.00046	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.88e-06	0.000459	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.8e-06	0.00045	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.74e-06	0.000442	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.68e-06	0.000435	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.66e-06	0.000433	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.56e-06	0.000422	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.56e-06	0.000421	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.56e-06	0.000421	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.5e-06	0.000414	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	3.49e-06	0.000413	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.45e-06	0.000408	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.44e-06	0.000407	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	3.43e-06	0.000406	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.31e-06	0.000392	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.25e-06	0.000384	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	3.22e-06	0.000381	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	3.2e-06	0.000378	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.13e-06	0.00037	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.13e-06	0.00037	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.08e-06	0.000365	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.06e-06	0.000362	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.05e-06	0.00036	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3e-06	0.000355	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	2.93e-06	0.000347	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.88e-06	0.00034	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.87e-06	0.000339	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.87e-06	0.000339	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.82e-06	0.000333	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.81e-06	0.000332	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.75e-06	0.000325	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.74e-06	0.000324	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.67e-06	0.000316	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.65e-06	0.000313	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.65e-06	0.000313	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.53e-06	0.000299	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.51e-06	0.000297	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.49e-06	0.000295	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.43e-06	0.000288	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	2.37e-06	0.00028	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.37e-06	0.00028	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.36e-06	0.000279	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.32e-06	0.000274	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	2.31e-06	0.000274	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.21e-06	0.000261	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.19e-06	0.000259	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.18e-06	0.000257	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.17e-06	0.000257	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.16e-06	0.000255	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.14e-06	0.000254	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.11e-06	0.000249	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.01e-06	0.000238	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	2e-06	0.000237	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2e-06	0.000236	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.99e-06	0.000235	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.98e-06	0.000234	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.95e-06	0.00023	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.92e-06	0.000227	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.84e-06	0.000218	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	1.79e-06	0.000211	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.79e-06	0.000211	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.7e-06	0.000201	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.69e-06	0.0002	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	1.64e-06	0.000195	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.63e-06	0.000193	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.62e-06	0.000192	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.61e-06	0.00019	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.58e-06	0.000187	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.5e-06	0.000177	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.48e-06	0.000174	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.44e-06	0.000171	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.42e-06	0.000168	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.42e-06	0.000168	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.39e-06	0.000165	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.39e-06	0.000165	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.37e-06	0.000162	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.35e-06	0.00016	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.31e-06	0.000155	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.27e-06	0.00015	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.25e-06	0.000148	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.23e-06	0.000145	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.13e-06	0.000133	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.12e-06	0.000132	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.09e-06	0.000129	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.08e-06	0.000127	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.62e-07	0.000114	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.55e-07	0.000113	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.46e-07	0.000112	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.37e-07	8.71e-05	CbGpPWpGaD
